Fondation A De Rothschild

The medical center is at the forefront of ophthalmology research, focusing on innovative treatments for various eye conditions. The center's work in this field is driven by a commitment to improving visual outcomes and quality of life for patients.

• Diabetic Macular Edema
• Age-Related Macular Degeneration
• Choroidal Neovascularization
• Macular Telangiectasia
• Central Retinal Vein Occlusions
• Coats' Disease
• Retinoblastoma

Through cutting-edge clinical trials, the center is pioneering new therapies that aim to halt or reverse the progression of these debilitating conditions.

Specializing in neurology, the center is dedicated to advancing the understanding and treatment of neurological disorders. The research conducted here is instrumental in developing new therapeutic strategies for complex conditions.

• Alzheimer's Disease
• Tourette's Disorder
• Myasthenia Gravis
• Stroke and Ischemic Conditions
• Subarachnoid Hemorrhage
• Fuchs Endothelial Corneal Dystrophy

The center's research is pivotal in enhancing the efficacy and safety of treatments, offering hope for improved patient outcomes.

In the realm of cardiology and vascular medicine, the center is renowned for its research into innovative treatments for cardiovascular diseases. The focus is on improving patient care through advanced therapeutic interventions.

• Ischemic Stroke
• Coronary Syndrome
• Atherosclerosis
• Myocardial Infarction

By exploring new treatment modalities, the center aims to reduce the burden of cardiovascular diseases and enhance the quality of life for patients.

The center is a leader in rheumatology and autoimmune disease research, focusing on innovative therapies to manage and treat these complex conditions. The research is aimed at improving patient outcomes and quality of life.

• Granulomatosis with Polyangiitis
• Behçet’s Disease
• Multiple Sclerosis

Through rigorous clinical trials, the center is developing new strategies to effectively manage these challenging diseases.

Focusing on genetic and metabolic disorders, the center is pioneering research into novel treatments that address the underlying causes of these conditions. The goal is to improve patient care and outcomes through targeted therapies.

• Wilson Disease
• Acquired Blepharoptosis

The center's research is crucial in developing therapies that offer hope for patients with these rare and challenging disorders.